These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 21668038)

  • 1. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.
    Ding Q; Luckhardt T; Hecker L; Zhou Y; Liu G; Antony VB; deAndrade J; Thannickal VJ
    Drugs; 2011 May; 71(8):981-1001. PubMed ID: 21668038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis.
    Phan THG; Paliogiannis P; Nasrallah GK; Giordo R; Eid AH; Fois AG; Zinellu A; Mangoni AA; Pintus G
    Cell Mol Life Sci; 2021 Mar; 78(5):2031-2057. PubMed ID: 33201251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis.
    Kliment CR; Oury TD
    Free Radic Biol Med; 2010 Sep; 49(5):707-17. PubMed ID: 20452419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis.
    Kropski JA; Lawson WE; Young LR; Blackwell TS
    Dis Model Mech; 2013 Jan; 6(1):9-17. PubMed ID: 23268535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Innovative therapeutics for idiopathic pulmonary fibrosis].
    Uzunhan Y; Nunes H; Gille T; Bron C; Planès C; Valeyre D
    Presse Med; 2011 Dec; 40(12 Pt 1):1100-12. PubMed ID: 21890312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highlights on Future Treatments of IPF: Clues and Pitfalls.
    Libra A; Sciacca E; Muscato G; Sambataro G; Spicuzza L; Vancheri C
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39125962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.
    Horowitz JC; Thannickal VJ
    Treat Respir Med; 2006; 5(5):325-42. PubMed ID: 16928146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bleomycin Model of Pulmonary Fibrosis.
    Liu T; De Los Santos FG; Phan SH
    Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary fibrosis: patterns and perpetrators.
    Noble PW; Barkauskas CE; Jiang D
    J Clin Invest; 2012 Aug; 122(8):2756-62. PubMed ID: 22850886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular senescence and autophagy in the pathogenesis of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF).
    Kuwano K; Araya J; Hara H; Minagawa S; Takasaka N; Ito S; Kobayashi K; Nakayama K
    Respir Investig; 2016 Nov; 54(6):397-406. PubMed ID: 27886850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic Cells Are the Intriguing Players in the Puzzle of Idiopathic Pulmonary Fibrosis Pathogenesis.
    Bocchino M; Zanotta S; Capitelli L; Galati D
    Front Immunol; 2021; 12():664109. PubMed ID: 33995394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutics based on emerging concepts in pulmonary fibrosis.
    Sontake V; Gajjala PR; Kasam RK; Madala SK
    Expert Opin Ther Targets; 2019 Jan; 23(1):69-81. PubMed ID: 30468628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senotherapeutics: Targeting senescence in idiopathic pulmonary fibrosis.
    Merkt W; Bueno M; Mora AL; Lagares D
    Semin Cell Dev Biol; 2020 May; 101():104-110. PubMed ID: 31879264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer.
    Tzouvelekis A; Gomatou G; Bouros E; Trigidou R; Tzilas V; Bouros D
    Chest; 2019 Aug; 156(2):383-391. PubMed ID: 31125557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis.
    Tanjore H; Blackwell TS; Lawson WE
    Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(8):L721-9. PubMed ID: 22287606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging therapeutic interventions for idiopathic pulmonary fibrosis.
    Chakraborty S; Chopra P; Ambi SV; Dastidar SG; Ray A
    Expert Opin Investig Drugs; 2014 Jul; 23(7):893-910. PubMed ID: 24766571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell and Idiopathic Pulmonary Fibrosis: Mechanisms and Treatment.
    Liu M; Ren D; Wu D; Zheng J; Tu W
    Curr Stem Cell Res Ther; 2015; 10(6):466-76. PubMed ID: 25986617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
    Pardo A; Selman M
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment.
    Li S; Zhao J; Shang D; Kass DJ; Zhao Y
    JCI Insight; 2018 May; 3(10):. PubMed ID: 29769446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatics in idiopathic pulmonary fibrosis: new insights into an old disease.
    El-Chemaly S; Pacheco-Rodriguez G; Ikeda Y; Malide D; Moss J
    Lymphat Res Biol; 2009 Dec; 7(4):197-203. PubMed ID: 20143918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.